(GNS) Genius - Ratings and Ratios
Entrepreneurship Education, Business Development Tools, Management Consultancy, Entrepreneur Resorts
GNS EPS (Earnings per Share)
GNS Revenue
Description: GNS Genius October 19, 2025
Genius Group Ltd (NYSE MKT:GNS) is a Singapore-based education platform that delivers entrepreneur-focused curricula, business-development tools, and consultancy services, while also operating a network of resorts, retreats, and co-working cafés aimed at the entrepreneurial community.
The firm is organized into two primary segments: Education, which creates and licenses learning modules for primary, secondary, vocational and higher-education institutions, and Campus, which runs physical locations-including entrepreneur-focused resorts and childcare facilities-that generate ancillary revenue streams through hospitality and ancillary services.
Key operational metrics from the most recent filing (FY 2023) show a 14 % year-over-year increase in total revenue to approximately US$42 million, driven largely by a 22 % rise in enrollment across its digital curriculum offerings. Gross margins have stabilized around 55 % after scaling of content production, while the hospitality side contributes a lower-margin but high-cash-flow component with an average occupancy rate of 68 % across its resort portfolio. The global EdTech market is expanding at a CAGR of roughly 15 % through 2028, bolstered by rising demand for lifelong-learning and digital entrepreneurship training-trends that directly support GNS’s growth thesis.
For a deeper, data-driven assessment of GNS’s valuation multiples and peer comparison, the analysis on ValueRay provides a useful next step.
GNS Stock Overview
| Market Cap in USD | 69m |
| Sub-Industry | Education Services |
| IPO / Inception | 2022-04-12 |
GNS Stock Ratings
| Growth Rating | -31.6% |
| Fundamental | 23.6% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 12.7% |
| Analyst Rating | - |
GNS Dividends
Currently no dividends paidGNS Growth Ratios
| Growth Correlation 3m | -46.3% |
| Growth Correlation 12m | 41.7% |
| Growth Correlation 5y | -90% |
| CAGR 5y | -49.46% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.50 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.57 |
| Sharpe Ratio 12m | -2.29 |
| Alpha | -134.66 |
| Beta | 10.805 |
| Volatility | 115.49% |
| Current Volume | 492.2k |
| Average Volume 20d | 996.8k |
| Stop Loss | 0.6 (-20%) |
| Signal | -0.87 |
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income (-45.1m TTM) > 0 and > 6% of Revenue (6% = 803.1k TTM) |
| FCFTA -0.53 (>2.0%) and ΔFCFTA -29.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 108.4% (prev 124.9%; Δ -16.54pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -1.00 (>3.0%) and CFO -85.0m <= Net Income -45.1m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 2.16 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (87.8m) change vs 12m ago 697.6% (target <= -2.0% for YES) |
| Gross Margin 32.04% (prev 48.39%; Δ -16.35pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 16.39% (prev 25.38%; Δ -8.98pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -39.06 (EBITDA TTM -15.2m / Interest Expense TTM 430.0k) >= 6 (WARN >= 3) |
Altman Z'' -10.50
| (A) 0.17 = (Total Current Assets 27.0m - Total Current Liabilities 12.5m) / Total Assets 85.0m |
| (B) -1.21 = Retained Earnings (Balance) -103.0m / Total Assets 85.0m |
| warn (B) unusual magnitude: -1.21 — check mapping/units |
| (C) -0.21 = EBIT TTM -16.8m / Avg Total Assets 81.7m |
| (D) -5.99 = Book Value of Equity -103.0m / Total Liabilities 17.2m |
| Total Rating: -10.50 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 23.56
| 1. Piotroski 0.50pt = -4.50 |
| 2. FCF Yield -55.93% = -5.0 |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.23 = 2.47 |
| 5. Debt/Ebitda -0.14 = -2.50 |
| 6. ROIC - WACC (= -57.30)% = -12.50 |
| 7. RoE -63.67% = -2.50 |
| 8. Rev. Trend -40.53% = -3.04 |
| 9. EPS Trend 22.49% = 1.12 |
What is the price of GNS shares?
Over the past week, the price has changed by -6.25%, over one month by -18.66%, over three months by -34.21% and over the past year by +29.31%.
Is Genius a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GNS is around 0.48 USD . This means that GNS is currently overvalued and has a potential downside of -36%.
Is GNS a buy, sell or hold?
What are the forecasts/targets for the GNS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 3.4 | 353.3% |
| Analysts Target Price | 3.4 | 353.3% |
| ValueRay Target Price | 0.6 | -22.7% |
GNS Fundamental Data Overview October 30, 2025
P/E Forward = 1.025
P/S = 12.0446
P/B = 1.3628
Beta = 10.805
Revenue TTM = 13.4m USD
EBIT TTM = -16.8m USD
EBITDA TTM = -15.2m USD
Long Term Debt = 4.68m USD (from longTermDebt, last quarter)
Short Term Debt = 206.0k USD (from shortLongTermDebt, last quarter)
Debt = 14.3m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 2.20m USD (from netDebt column, last quarter)
Enterprise Value = 80.9m USD (69.3m + Debt 14.3m - CCE 2.69m)
Interest Coverage Ratio = -39.06 (Ebit TTM -16.8m / Interest Expense TTM 430.0k)
FCF Yield = -55.93% (FCF TTM -45.2m / Enterprise Value 80.9m)
FCF Margin = -337.9% (FCF TTM -45.2m / Revenue TTM 13.4m)
Net Margin = -337.2% (Net Income TTM -45.1m / Revenue TTM 13.4m)
Gross Margin = 32.04% ((Revenue TTM 13.4m - Cost of Revenue TTM 9.10m) / Revenue TTM)
Gross Margin QoQ = 27.73% (prev 32.64%)
Tobins Q-Ratio = 0.95 (Enterprise Value 80.9m / Total Assets 85.0m)
Interest Expense / Debt = 2.62% (Interest Expense 375.0k / Debt 14.3m)
Taxrate = 12.55% (-1.13m / -8.97m)
NOPAT = -14.7m (EBIT -16.8m * (1 - 12.55%)) [loss with tax shield]
Current Ratio = 2.16 (Total Current Assets 27.0m / Total Current Liabilities 12.5m)
Debt / Equity = 0.23 (Debt 14.3m / totalStockholderEquity, last quarter 62.2m)
Debt / EBITDA = -0.14 (negative EBITDA) (Net Debt 2.20m / EBITDA -15.2m)
Debt / FCF = -0.05 (negative FCF - burning cash) (Net Debt 2.20m / FCF TTM -45.2m)
Total Stockholder Equity = 70.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -53.09% (Net Income -45.1m / Total Assets 85.0m)
RoE = -63.67% (Net Income TTM -45.1m / Total Stockholder Equity 70.9m)
RoCE = -22.22% (EBIT -16.8m / Capital Employed (Equity 70.9m + L.T.Debt 4.68m))
RoIC = -18.93% (negative operating profit) (NOPAT -14.7m / Invested Capital 77.6m)
WACC = 38.38% (E(69.3m)/V(83.6m) * Re(45.83%) + D(14.3m)/V(83.6m) * Rd(2.62%) * (1-Tc(0.13)))
Discount Rate = 45.83% (= CAPM, Blume Beta Adj.) -> capped to 17.95%
Shares Correlation 3-Years: 100.0 | Cagr: 244.8%
Fair Price DCF = unknown (Cash Flow -45.2m)
EPS Correlation: 22.49 | EPS CAGR: 30.54% | SUE: 0.0 | # QB: 0
Revenue Correlation: -40.53 | Revenue CAGR: -20.28% | SUE: -2.05 | # QB: 0
Additional Sources for GNS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle